-
Mashup Score: 5Nivolumab/Ipilimumab Maintains Prolonged Survival and Generates Durable Responses in Advanced RCC - 4 day(s) ago
First-line nivolumab/ipilimumab demonstrated sustained survival signals and responses vs sunitinib in previously untreated advanced RCC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and compared the use of single agent vs doublet immunotherapy in the PD-L1–low setting.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Neal E. Ready, MD, and participants discussed use of PD-L1 status in #NSCLC and compared the use of single agent vs doublet immunotherapy in the PD-L1–low setting. #lcsm | @DukeCancer https://t.co/o2tYIQaqzL
-
-
Mashup Score: 5Neoadjuvant Alectinib Yields Responses in Late-Stage, Potentially Resectable ALK+ NSCLC - 5 day(s) ago
Neoadjuvant alectinib produced major pathologic responses, and it was tolerable and feasible in potentially resectable, stage III, ALK-positive NSCLC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Neoadjuvant Alectinib Yields Responses in Late-Stage, Potentially Resectable ALK+ NSCLC @ASCO #ASCO25 #lcsm #oncology https://t.co/jfP5LoxD4S
-
-
Mashup Score: 34Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review - 6 day(s) ago
Abstract. The disease shift of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL), so-called Richter transformation (RT), is a cat
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
The disease shift of chronic lymphocytic leukemia to diffuse large B-cell lymphoma, so-called Richter transformation, is a catastrophic clinical event. https://t.co/kI4OnsUmdf #lymphoidneoplasia https://t.co/ZtNaFd8Sr3
-
-
Mashup Score: 3Clinical Education Conference - 6 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
Calling all APPs, nurses, fellows & in-training professionals! Gain a deeper understanding of diagnostic evaluations & treatments for acute & chronic complications of #HSCT & cellular therapies at the Clinical Education Conference. Register now: https://t.co/kN19YUV2kK #CEC24 https://t.co/WN2MHmwaJ3
-
-
Mashup Score: 1Cilta-Cel Bests SOC in Refractory Multiple Myeloma - 6 day(s) ago
Cilta-cel therapy significantly enhances survival rates in lenalidomide-refractory multiple myeloma, outperforming standard treatments in recent trials.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Cilta-cel has shown remarkable results, significantly boosting overall survival in patients with lenalidomide-refractory multiple myeloma compared with standard care. Discover more from #EBMT25: https://t.co/EXkN6T6soK
-
-
Mashup Score: 3Annual Conference - 7 day(s) ago
Orlando World Center Marriott • Orlando, FL | Virtual attendance also available Friday, April 5, 2024 – Sunday, April 7, 2024 | Nursing Program Educational topics focus on updates to NCCN Guidelines ® across many cancer types—plus screening, prevention, supportive care, data collection and utilization, care team collaboration, and much more! Those attending in-person can experience all the conference offers, including: Exclusive opportunities to Continue the Conversation with Experts Follow the Expert-guid
Source: www.nccn.orgCategories: General Medicine News, Onc News and JournalsTweet-
We are excited to invite you to this year’s 2024 Annual Conference. Educational topics focus on updates to NCCN Guidelines® across many cancer types—plus screening, prevention, supportive care, data collection, and much more! Register today: https://t.co/6voLOVEHru https://t.co/qeodDdXloY
-
-
Mashup Score: 18CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society | a podcast by ACS Journal Cancer - 7 day(s) ago
CancerSpeak is a podcast from CANCER, an interdisciplinary international journal of the American Cancer Society. Since 1948, CANCER has published high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. E…
Source: cancerspeak.podbean.comCategories: General Medicine News, Onc News and JournalsTweet-
📣 We are thrilled to announce the launch of our official podcast, CancerSpeak! 📗🎙️ Listen to the first 4 episodes of CancerSpeak featuring a conversation between @NNRTnews members on #PatientNavigation and cancer care 👇 https://t.co/wNmDRb0RlK https://t.co/CD0ogBbUNU
-
-
Mashup Score: 9Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review - 7 day(s) ago
Abstract. The disease shift of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL), so-called Richter transformation (RT), is a cat
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review https://t.co/HMHbmJio7S #lymphoidneoplasia https://t.co/cfn0A00lI8
-
-
Mashup Score: 4VJHemOnc – The video journal of hematological oncology - 7 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!📍 We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
Nivolumab/Ipilimumab Maintains Prolonged Survival and Generates Durable Responses in Advanced RCC #RCC #kcsm #ASCO25 @ASCO https://t.co/splOFvySGT